Shattuck Labs, Inc. (STTK) Stock: News, Analysis, Q&A, and Insights

Investment Analysis Report: STTK

Overview:

STTK is a company operating in the Health Technology sector, specifically in the Biotechnology industry. The company has a market capitalization of $482.82 million. In this report, we will conduct a detailed analysis of STTK's financial health, earnings and revenue growth, profitability, operating margi...

Technical Analysis of STTK 2024-04-26

Overview:

In analyzing the technical indicators for STTK over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days. By examining these key aspects, we aim to offer valuable insights and predictions to guide your invest...

Recent News & Updates

2024-04-18 09:05
Owning 36% shares,institutional owners seem interested in Shattuck Labs, Inc. (NASDAQ:STTK),(Simply Wall St.)
2024-04-09 16:05
Shattuck Labs Announces Oral Presentation of Preclinical Data at the American Association for Cancer Research (AACR) Annual Meeting 2024(GlobeNewswire)
2024-04-09 04:05
Shattuck Labs Announces Oral Presentation of Preclinical Data at the American Association for Cancer Research (AACR) Annual Meeting 2024(Globenewswire)
2024-04-01 07:00
Shattuck Labs Announces Participation in Upcoming 23rd Annual Needham Virtual Healthcare Conference(GlobeNewswire)
2024-03-31 19:00
Shattuck Labs Announces Participation in Upcoming 23rd Annual Needham Virtual Healthcare Conference(Globenewswire)
2024-03-05 13:40
Shattuck Labs Full Year 2023 Earnings: Beats Expectations(Simply Wall St.)
2024-03-04 07:00
Shattuck Labs Announces Appointment of Clay Siegall, Ph.D., and Kate Sasser, Ph.D., to its Board of Directors(GlobeNewswire)
2024-03-03 18:00
Shattuck Labs Announces Appointment of Clay Siegall, Ph.D., and Kate Sasser, Ph.D., to its Board of Directors(Globenewswire)
2024-02-29 16:05
Shattuck Labs Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Business Highlights(GlobeNewswire)
2024-02-29 03:05
Shattuck Labs Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Business Highlights(Globenewswire)
2024-02-26 07:00
Shattuck Labs Announces Participation in Upcoming March Conferences(GlobeNewswire)
2024-02-25 18:00
Shattuck Labs Announces Participation in Upcoming March Conferences(Globenewswire)
2024-02-14 05:06
Ono Enters into a Drug Discovery Collaboration and Option Agreement with Shattuck Labs to Generate Bifunctional Fusion Proteins(PR Newswire)
2024-02-13 16:06
Ono Enters into a Drug Discovery Collaboration and Option Agreement with Shattuck Labs to Generate Bifunctional Fusion Proteins(Prnewswire)
2024-02-13 06:00
Shattuck Labs Enters into Strategic Collaboration and License Agreement with Ono Pharmaceutical to Generate Bifunctional Fusion Proteins for the Treatment of Autoimmune and Inflammatory Diseases(GlobeNewswire)
2024-02-12 17:00
Shattuck Labs Enters into Strategic Collaboration and License Agreement with Ono Pharmaceutical to Generate Bifunctional Fusion Proteins for the Treatment of Autoimmune and Inflammatory Diseases(Globenewswire)
2024-01-08 07:00
Shattuck Labs Provides Corporate Update and Highlights Upcoming Key Milestones in 2024(GlobeNewswire)
2024-01-07 18:00
Shattuck Labs Provides Corporate Update and Highlights Upcoming Key Milestones in 2024(Globenewswire)
2024-01-04 16:05
Shattuck Labs Announces Presentation at Upcoming 42nd Annual J.P. Morgan Healthcare Conference(GlobeNewswire)
2024-01-04 03:05
Shattuck Labs Announces Presentation at Upcoming 42nd Annual J.P. Morgan Healthcare Conference(Globenewswire)
2023-12-21 08:00
Shattuck Labs Announces $50 Million Public Offering of Common Stock and Concurrent Private Placement of Pre-Funded Warrants(GlobeNewswire)
2023-12-21 05:14
We're Keeping An Eye On Shattuck Labs' (NASDAQ:STTK) Cash Burn Rate(Simply Wall St.)
2023-12-20 19:00
Shattuck Labs Announces $50 Million Public Offering of Common Stock and Concurrent Private Placement of Pre-Funded Warrants(Globenewswire)
2023-12-13 06:00
Shattuck Labs Announces Positive Initial Topline Data from Ongoing Phase 1 A/B Dose Expansion Clinical Trial of SL-172154 with Azacitidine in Frontline Higher-Risk Myelodysplastic Syndromes (HR-MDS) and TP53 mutant (TP53m) Acute Myeloid Leukemia (AML) Pati(GlobeNewswire)
2023-12-12 21:45
Why Is Shattuck Labs (STTK) Stock Up 93% Today?(Investorplace)
2023-12-12 17:00
Shattuck Labs Announces Positive Initial Topline Data from Ongoing Phase 1 A/B Dose Expansion Clinical Trial of SL-172154 with Azacitidine in Frontline Higher-Risk Myelodysplastic Syndromes (HR-MDS) and TP53 mutant (TP53m) Acute Myeloid Leukemia (AML) Pati(Globenewswire)
2023-12-05 16:15
Shattuck Labs to Host Investor Call and Webcast to Share Initial Clinical Trial Data from Phase 1A/B Dose-Expansion Cohorts in Frontline Higher-Risk Myelodysplastic Syndromes (HR-MDS) and TP53m Acute Myeloid Leukemia (AML) and Review of Dose-Escalation Dat(GlobeNewswire)
2023-12-05 03:15
Shattuck Labs to Host Investor Call and Webcast to Share Initial Clinical Trial Data from Phase 1A/B Dose-Expansion Cohorts in Frontline Higher-Risk Myelodysplastic Syndromes (HR-MDS) and TP53m Acute Myeloid Leukemia (AML) and Review of Dose-Escalation Dat(Globenewswire)
2023-11-14 09:00
Shattuck Labs Announces Participation in Upcoming 6th Annual Evercore ISI HealthCONx Conference(GlobeNewswire)
2023-11-13 20:00
Shattuck Labs Announces Participation in Upcoming 6th Annual Evercore ISI HealthCONx Conference(Globenewswire)

Page 1 of 5

previousnext

STTK

Performance

Profile

Investment Analysis Report: STTK

Overview:

Technical Analysis of STTK 2024-04-26

Overview:

Recent News & Updates

Services

Resources